4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155966
Options or other derivatives
- President and CEO acquired 169,866 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-12-15 | Grant or award : show line 1 in the form Stock option (right to buy) | +145,600 | 145,600 | D |
| 2016-12-15 | Grant or award : show line 2 in the form Restricted stock units | +24,266 | 24,266 | D |
Loading xslF345X03/doc4.xml…